Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar.
Chiew
Yoke-Fong
YF
Charles
Musuka
M
Johnstone
Maree C
MC
Thompson
Kim M
KM
Parnell
Kyle D
KD
Penno
Erin C
EC
D000081:Acetamides / Q000627:therapeutic use; D000208:Acute Disease; D000328:Adult; D000362:Agar; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D004351:Drug Resistance; D006801:Humans; D016867:Immunocompromised Host; D007951:Leukemia, Myeloid / Q000628:therapy; D000069349:Linezolid; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods*; D023303:Oxazolidinones / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology; D013212:Staphylococcus epidermidis / Q000187:drug effects; D041162:Staphylococcus haemolyticus / Q000187:drug effects; D014640:Vancomycin / Q000627:therapeutic use*
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000362:Agar; D000069349:Linezolid